Equity
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2019
Last reportedQ1 2026May 1, 2026
How to read this metric
An increase indicates the issuance of new preferred equity to raise capital, while a decrease reflects the redemption or conversion of these shares.
Detailed definition
The par value of preferred shares authorized and issued by the company. Preferred stock typically carries specific right...
Peer comparison
Most mature medical device companies maintain minimal or zero preferred stock, relying on common equity or debt.
Metric ID:
equity_preferred_stock_valueHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Range$0 – $0
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding at Other Companies
Frequently Asked Questions
- What is Boston Scientific's preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding?
- Boston Scientific (BSX) reported preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding of $0 in Q1 2026.
- What does preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding mean?
- The total value of shares that have priority over common stock for dividends and assets.